Responders (n = 2) | Non-responders (n = 12) | |
Age at antagonist (years) | 81.5 ± 7.8 | 81.4 ± 4.0 |
Duration of agonist (months) | 80.0 ± 61.0 | 79.6± 67.1 |
Mean number of anti-androgen before antagonist | 3.5 | 2.6 |
PSA velocity (ng/mL/year) | 3.4 ± 2.7 | 49.9 ± 69.8 |
PSA (ng/mL) | ||
before | 4.0 ± 1.4 | 32.7 ± 36.3 |
after | 3.5 ± 69.8 | 64.6 ± 62.4 |
% change from baseline | −8.5% | 123.30% |
Testosterone (ng/mL) | ||
before | <0.03 | 0.035 ± 0.01 |
after | <0.03 | 0.035 ± 0.01 |
FSH (mIU/mL) | ||
before | 0.48 ± 0.6 | 3.8 ± 2.6 |
after | 0.56 ± 0.7 | 2.7 ± 1.9 |
LH (mIU/mL) | ||
before | <0.1 | <0.1 |
after | <0.1 | <0.1 |